Search

everythinglearnresearchcommunity

for

Search:↓

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Combining different treatments may be needed to effectively manage chronic prostatitis.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Understanding patients' views on their illness can help improve their disease management.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The hydrogel dressing speeds up and improves diabetic wound healing.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Enriching the French health care database with external data greatly improved its usefulness.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

Ptprq has multiple forms that change during inner ear development.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

MDP hydrogel heals wounds faster and better than other treatments in diabetic mice.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.